Chargement en cours...
Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma
Checkpoint inhibitors are a novel option in the management of metastatic melanomas and many other malignancies. They are used to promote the activation of cytotoxic T-lymphocytes by inhibiting deactivation signals, enabling the immune response to the tumor. Numerous Immune-related adverse effects ca...
Enregistré dans:
| Publié dans: | Eur J Rheumatol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medical Research and Education Association
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668642/ https://ncbi.nlm.nih.gov/pubmed/30986169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2019.18159 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|